Table 7.

In each of the 11 experiments, 20 top-ranked significant tissues whose set of upregulated genes significantly overlapped with the set of genes selected for each experiment were identified.

Exp.	#	(i)	(ii)	(iii)	(iv)	(v)	(vi)	(vii)	(viii)	(ix)	(x)
1	(232)	68/1509	51/1066	65/1384	74/1773	77/1764		69/1770		53/1174	68/1710
	[216]	$1.11\times {10}^{20}$	$3.65\times {10}^{16}$	$1.28\times {10}^{20}$	$8.31\times {10}^{21}$	$8.66\times {10}^{23}$		$8.65\times {10}^{18}$		$8.12\times {10}^{16}$	$7.14\times {10}^{18}$
2	(711)						78/625
	[470]						$3.13\times {10}^{20}$
3	(747)						72/625
	[441]						$1.93\times {10}^{15}$
4	(441)	80/1509	61/1066	82/1384		87/1764	54/625		54/525
	[151]	$3.20\times {10}^{11}$	$1.01\times {10}^9$	$7.82\times {10}^{14}$		$1.08\times {10}^5$	$6.23\times {10}^{15}$		$6.83\times {10}^{18}$
5	(123)	31/1509	29/1066	32/1384	33/1773			34/1770		26/1174	33/1710
	[150]	$2.48\times {10}^7$	$9.29\times {10}^9$	$1.75\times {10}^8$	$5.68\times {10}^7$			$1.99\times {10}^7$		$9.17\times {10}^7$	$2.90\times {10}^7$
6	(292)	80/1509	66/1066	70/1384	80/1773	85/1764	46/625	78/1770	50/525	63/1174	76/1710
	[196]	$7.02\times {10}^{22}$	$3.72\times {10}^{21}$	$4.91\times {10}^{18}$	$4.91\times {10}^{18}$	$4.97\times {10}^{21}$	$2.53\times {10}^{17}$	$4.73\times {10}^{17}$	$4.99\times {10}^{23}$	$2.53\times {10}^{17}$	$7.45\times {10}^{17}$
7	(246)	64/1509	53/1066	57/1384	68/1773	68/1764	34/625	63/1770	35/525	52/1174	63/1710
	[135]	$7.77\times {10}^{16}$	$1.13\times {10}^{15}$	$1.02\times {10}^{13}$	$3.42\times {10}^{15}$	$3.28\times {10}^{15}$	$5.23\times {10}^{11}$	$1.16\times {10}^{12}$	$1.03\times {10}^{13}$	$1.10\times {10}^{13}$	$2.75\times {10}^{13}$
8	(873)	164/1509	131/1066	156/1384	155/1773	168/1764		161/1770		128/1174	157/1710
	[178]	$1.61\times {10}^{25}$	$8.18\times {10}^{25}$	$1.61\times {10}^{25}$	$2.25\times {10}^{15}$	$4.48\times {10}^{20}$		$2.02\times {10}^{17}$		$1.31\times {10}^{19}$	$2.38\times {10}^{17}$
9	(119)	39/1509	28/1066	40/1384	38/1773	37/1764	24/625		25/525
	[225]	$1.13\times {10}^{13}$	$8.60\times {10}^{10}$	$2.22\times {10}^{15}$	$5.07\times {10}^{11}$	$1.92\times {10}^{10}$	$3.31\times {10}^{11}$		$1.13\times {10}^{13}$
10	(104)	29/1509	22/1066	30/1384	31/1773	29/1764		28/1770	15/525	23/1174	27/1710
	[156]	$2.83\times {10}^7$	$5.82\times {10}^6$	$1.93\times {10}^8$	$4.52\times {10}^7$	$4.31\times {10}^6$		$1.19\times {10}^5$	$1.35\times {10}^5$	$5.82\times {10}^6$	$1.51\times {10}^5$
11	(120)						13/625		12/525
	[5]						$1.54\times {10}^2$		$1.38\times {10}^2$

(i) GTEX-QDT8-0011-R10A-SM-32PKG_brain_female_30-39_years; (ii) GTEX-QMR6-1426-SM-32PLA_brain_male_50-59_years; (iii) GTEX-TSE9-3026-SM-3DB76_brain_female_60-69_years; (iv) GTEX-PVOW-0011-R3A-SM-32PKX_brain_male_40-49_years; (v) GTEX-PVOW-2526-SM-2XCF7_brain_male_40-49_years; (vi) GTEX-XAJ8-1326-SM-47JYT_testis_male_40-49_years; (vii) GTEX-N7MS-0011-R3a-SM-33HC6_brain_male_60-69_years; (viii) GTEX-OHPM-2126-SM-3LK75_testis_male_50-59_years; (ix) GTEX-PVOW-0011-R5A-SM-32PL7_brain_male_40-49_years; and (x) GTEX-PVOW-2626-SM-32PL8_brain_male_40-49_years. (numbers): gene; [numbers]: tissues. P-values are the ones adjusted by Enrichr.